Articles producció científica> Medicina i Cirurgia

Soluble transferrin receptor and risk of type 2 diabetes in the obese and non-obese.

  • Identification data

    Identifier:  imarina:2633171
    Authors:  Fernandez-Cao, Jose C; Arija, Victoria; Aranda, Nuria; Basora, Josep; Diez-Espino, Javier; Estruch, Ramon; Fito, Montse; Corella, Dolores; Salas-Salvado, Jordi
    Abstract:
    Studies evaluating the relationship between soluble transferrin receptor (sTfR), a biomarker inversely related to body iron stores, and risk of type 2 diabetes mellitus (T2DM) are scarce and inconclusive. Furthermore, sTfR concentrations have been observed to be significantly higher in obese than in nonobese individuals. Therefore, the aim of this study was to assess the relationship between sTfR and the risk of T2DM in obese and nonobese subjects.A nested case-control study of 153 cases of newly diagnosed diabetic subjects, 73 obese and 80 nonobese, and 306 individually matched controls, 138 obese and 166 nonobese, who did not develop T2DM for a median 6-year follow-up (interquartile range: 3·9-6·5) was conducted using data from the PREvention with MEDiterranean Diet (PREDIMED) cohort (http://www.controlled-trials.com/ISRCTN35739639). Cases and controls were matched for age (? 67 vs. > 67 years), gender, dietary intervention group and BMI (? 27 vs. > 27 kg/m2 ).Waist circumference is the main determinant of sTfR concentrations in the whole sample (? = 0·476, P < 0·001), in the obese (? = 0·802, P < 0·001) and the nonobese (? = 0·455, P = 0·003). Furthermore, sTfR is directly associated with the risk of T2DM in obese individuals (OR = 2·79; 95% CI: 1·35-5·77, P = 0·005) and inversely associated in nonobese individuals (OR = 0·40; 95% CI: 0·20-0·79, P = 0·015).The association between sTfR levels and risk of T2DM in a population at high cardiovascular risk depend on the presence or absence of obesity. While in nonobese subjects elevated sTfR levels are associated with a decreased risk of developing T2DM, in obese subjects the risk increases. This suggests that obesity alters the relationship between sTfR and T2DM incidence.© 2017 Stichting European Society for Clinical In
  • Others:

    Author, as appears in the article.: Fernandez-Cao, Jose C; Arija, Victoria; Aranda, Nuria; Basora, Josep; Diez-Espino, Javier; Estruch, Ramon; Fito, Montse; Corella, Dolores; Salas-Salvado, Jordi
    Department: Bioquímica i Biotecnologia; Ciències Mèdiques Bàsiques; Medicina i Cirurgia; Ciències Mèdiques Bàsiques
    URV's Author/s: Aranda Pons, Núria / Arija Val, Maria Victoria / Basora Gallisa, Josep / Fernández Sáez, José / Salas Salvadó, Jorge
    Keywords: Type 2 diabetes mellitus; Type 2 diabetes; Soluble transferrin receptor; Risk factors; Receptors, transferrin; Predimed; Obesity; Nested case–control; Nested case-control; Middle aged; Male; Iron; Humans; Female; Diet, mediterranean; Diabetes mellitus, type 2; Case-control studies; Body iron stores; Blood glucose; Biomarkers; Aged, 80 and over; Aged; predimed
    Abstract: Studies evaluating the relationship between soluble transferrin receptor (sTfR), a biomarker inversely related to body iron stores, and risk of type 2 diabetes mellitus (T2DM) are scarce and inconclusive. Furthermore, sTfR concentrations have been observed to be significantly higher in obese than in nonobese individuals. Therefore, the aim of this study was to assess the relationship between sTfR and the risk of T2DM in obese and nonobese subjects.A nested case-control study of 153 cases of newly diagnosed diabetic subjects, 73 obese and 80 nonobese, and 306 individually matched controls, 138 obese and 166 nonobese, who did not develop T2DM for a median 6-year follow-up (interquartile range: 3·9-6·5) was conducted using data from the PREvention with MEDiterranean Diet (PREDIMED) cohort (http://www.controlled-trials.com/ISRCTN35739639). Cases and controls were matched for age (? 67 vs. > 67 years), gender, dietary intervention group and BMI (? 27 vs. > 27 kg/m2 ).Waist circumference is the main determinant of sTfR concentrations in the whole sample (? = 0·476, P < 0·001), in the obese (? = 0·802, P < 0·001) and the nonobese (? = 0·455, P = 0·003). Furthermore, sTfR is directly associated with the risk of T2DM in obese individuals (OR = 2·79; 95% CI: 1·35-5·77, P = 0·005) and inversely associated in nonobese individuals (OR = 0·40; 95% CI: 0·20-0·79, P = 0·015).The association between sTfR levels and risk of T2DM in a population at high cardiovascular risk depend on the presence or absence of obesity. While in nonobese subjects elevated sTfR levels are associated with a decreased risk of developing T2DM, in obese subjects the risk increases. This suggests that obesity alters the relationship between sTfR and T2DM incidence.© 2017 Stichting European Society for Clinical Investigation Journal Foundation.
    Thematic Areas: Saúde coletiva; Odontología; Nutrição; Medicine, research & experimental; Medicine, general & internal; Medicine (miscellaneous); Medicina ii; Medicina i; Interdisciplinar; General medicine; Farmacia; Educação física; Clinical biochemistry; Ciências biológicas iii; Ciências biológicas ii; Ciências biológicas i; Biotecnología; Biochemistry
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 00142972
    Author's mail: jose.fernandezs@urv.cat; josep.basora@urv.cat; nuria.aranda@urv.cat; jose.fernandezs@urv.cat; josep.basora@urv.cat; jordi.salas@urv.cat; victoria.arija@urv.cat
    Record's date: 2025-03-22
    Paper version: info:eu-repo/semantics/acceptedVersion
    Link to the original source: https://onlinelibrary.wiley.com/doi/abs/10.1111/eci.12725
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Paper original source: European Journal Of Clinical Investigation. 47 (3): 221-230
    APA: Fernandez-Cao, Jose C; Arija, Victoria; Aranda, Nuria; Basora, Josep; Diez-Espino, Javier; Estruch, Ramon; Fito, Montse; Corella, Dolores; Salas-Salva (2017). Soluble transferrin receptor and risk of type 2 diabetes in the obese and non-obese.. European Journal Of Clinical Investigation, 47(3), 221-230. DOI: 10.1111/eci.12725
    Article's DOI: 10.1111/eci.12725
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2017
    Publication Type: Journal Publications
  • Keywords:

    Biochemistry,Clinical Biochemistry,Medicine (Miscellaneous),Medicine, General & Internal,Medicine, Research & Experimental
    Type 2 diabetes mellitus
    Type 2 diabetes
    Soluble transferrin receptor
    Risk factors
    Receptors, transferrin
    Predimed
    Obesity
    Nested case–control
    Nested case-control
    Middle aged
    Male
    Iron
    Humans
    Female
    Diet, mediterranean
    Diabetes mellitus, type 2
    Case-control studies
    Body iron stores
    Blood glucose
    Biomarkers
    Aged, 80 and over
    Aged
    predimed
    Saúde coletiva
    Odontología
    Nutrição
    Medicine, research & experimental
    Medicine, general & internal
    Medicine (miscellaneous)
    Medicina ii
    Medicina i
    Interdisciplinar
    General medicine
    Farmacia
    Educação física
    Clinical biochemistry
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Biotecnología
    Biochemistry
  • Documents:

  • Cerca a google

    Search to google scholar